|
|
Please log in to determine if you are eligible to purchase PT Programs.
|
|
MINIMAL RESIDUAL DISEASE, BCR/ABL1 P210 - MRD |
MRD
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
- Three RNA specimens in sterile water
- For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of BCR/ABL1 fusion transcripts
- Ships on dry ice
Shipping Schedule
-
Shipment A: April 19
-
Shipment B: October 4
|
|
|
|
|
|